The Division of Cancer Treatment and Diagnosis (DCTD) collaborates with other National Cancer Institute (NCI) components as the world's largest sponsor of clinical cancer research.
The Breast Cancer Risk Assessment Tool is an interactive tool designed by scientists at the National Cancer Institute (NCI) and the National Surgical Adjuvant Breast and Bowel Project (NSABP) to estimate a woman's risk of developing invasive breast cancer.
Susan G. Komen for the Cure is fighting every minute of every day to finally, once and for all, finish what we started and achieve our vision of a world without breast cancer.
The National Gene Test Fund provides a resource to encourage discussion, action and funding of genetic testing for those people who are at high risk for genetically transmitted diseases and are willing to take preventative measures, but cannot afford the prohibitive costs of such testing.
Since 1991, the National Breast Cancer Coalition's trained advocates have lobbied at the national, state and local levels for public policies that impact breast cancer research, diagnosis and treatment.
The M.D. Anderson Cancer Center at the University of Texas.
CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access to breast and cervical cancer screening services to underserved women all 50 states, the District of Columbia, five U.S. territories, and 12 tribes.
BreastCancer.org is a non-profit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. Their mission is to help women and their loved ones make sense of the complex medical and personal information about breast cancer.
From BreastCancer.org, a comprehensive explanation of how to read and understand your pathology report.
The Cancer Center at Stanford designed by The National Cancer Institute.